Longmont, CO – Tekton Research, a prominent leader in clinical trials with a nationwide network of research facilities established in 2006, is excited to announce its recent partnership with Dr. Alex Reish. An esteemed osteopath specializing in migraines and chronic pain, Dr. Reish joins Tekton Research with a strong passion for innovative care and extensive experience. His unique and specialized expertise will significantly enrich Tekton’s growing team and enhance its commitment to advancing cutting-edge treatments.
Dr. Reish, a Colorado native, brings a wealth of experience in headache and pain management, with a particular focus on innovative, non-opioid treatment approaches. His addition marks a significant milestone in Tekton’s mission to advance CNS clinical research and expand access to cutting-edge treatments for patients suffering from neurological disorders.
Dr. Reish’s journey in medicine began at Denver’s Inner City Health Clinic, where he volunteered in high school, sparking his commitment to patient care. He later earned his undergraduate degree from the University of Colorado Boulder and gained hands-on experience at the People’s Clinic, serving vulnerable populations. His extensive residency training in Family Medicine, Osteopathic Manipulative Medicine, and Neuromusculoskeletal Medicine cemented his reputation as a trusted specialist in treating migraines and chronic pain.
With his large and growing patient database, and a flourishing practice in Boulder, Dr. Reish emphasizes patient-centered care and innovative solutions to complex conditions like fibromyalgia, irritable bowel syndrome (IBS), and Ehlers-Danlos Syndrome (EDS). His private practice, known for its tranquil and personalized atmosphere, reflects his commitment to providing a non-traditional medical environment where patients feel supported and valued.
Dr. Reish’s expertise and dedication to advancing neurological care align seamlessly with Tekton’s mission to drive forward CNS research. His collaboration with Tekton will focus on innovative clinical trials aimed at uncovering new treatments for migraines, chronic pain, and other neurological conditions that profoundly impact quality of life.
“Joining Tekton Research allows me to expand my work in a meaningful way,” said Dr. Reish. “By participating in clinical trials, I can help bring innovative treatments to patients who need them most. Tekton’s support gives me the opportunity to focus on advancing care while continuing to prioritize patient well-being.”
This partnership not only strengthens Tekton Research’s CNS research capabilities but also solidifies its position as a leader in neurology-focused clinical trials across the United States.
Jeffrey Zucker, VP of CNS/Neurology at Tekton Research, states: “With our continued growth in Neuroscience, Dr. Reish brings an important piece to our team. By having the ability to take on more complex migraine and headache trials as well as chronic pain, we are able to offer greater capabilities.”
Tekton Research enthusiastically welcomes Dr. Reish and is eager to leverage his expertise to further advance its CNS research initiatives, ultimately enhancing the company’s mission to deliver life-changing therapies for patients worldwide.
In tandem with this partnership, Tekton Research is proud to announce the upcoming launch of a new site in the Boulder, Colorado area, expanding its national footprint and capacity to conduct groundbreaking CNS clinical trials.
For more information or to schedule a meeting with Tekton’s Business Development team, please contact us at [email protected].
